KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $6.4 million.

  • Emergent BioSolutions' Tax Provisions fell 7681.16% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year decrease of 2307.69%. This contributed to the annual value of $47.7 million for FY2024, which is 6279.86% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Tax Provisions of $6.4 million as of Q3 2025, which was down 7681.16% from -$4.8 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Tax Provisions ranged from a high of $78.4 million in Q4 2021 and a low of -$26.4 million during Q2 2022
  • For the 5-year period, Emergent BioSolutions' Tax Provisions averaged around $9.8 million, with its median value being $5.6 million (2022).
  • In the last 5 years, Emergent BioSolutions' Tax Provisions plummeted by 111538.46% in 2022 and then skyrocketed by 2570000.0% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Tax Provisions (Quarter) stood at $78.4 million in 2021, then plummeted by 92.86% to $5.6 million in 2022, then tumbled by 189.29% to -$5.0 million in 2023, then surged by 174.0% to $3.7 million in 2024, then skyrocketed by 72.97% to $6.4 million in 2025.
  • Its last three reported values are $6.4 million in Q3 2025, -$4.8 million for Q2 2025, and $24.7 million during Q1 2025.